Add Yahoo as a preferred source to see more of our stories on Google. The national ADHD medicine shortage, which has impacted access to generic versions of Adderall, Vyvanse, and Concerta, was first ...

Misuse of stimulant medications for attention-deficit/hyperactivity disorder (ADHD) has declined sharply. In 2023, ...

Misuse of stimulant medications for attention deficit hyperactivity disorder (ADHD) has declined sharply. In 2023, ...

There are two groups of medications a doctor may prescribe for a child with ADHD. These include stimulants and nonstimulants. A doctor may recommend a combination of medications and behavioral ...

Initiating drug treatment forattention-deficit/hyperactivity disorder (ADHD) is associated with significantly lower all-cause mortality, particularly for deaths ...

Stimulants like methylphenidate (Ritalin, Concerta, and others) are the most commonly prescribed ADHD medications for children. They work by increasing brain chemicals such as dopamine and ...

Several units of a medication to treat ADHD have been recalled due to a low-volume concern after the capsules in lab tests failed to dissolve as expected. According to the U.S. Food and Drug ...

Amid rising diagnoses, a growing number of kids are getting prescriptions for ADHD medications — but the administered doses aren’t always accurate. Medication ...

Sep. 16—Now that school is back in session, children with attention deficit hyperactivity disorder are struggling with medications in short supply, area medical providers say. "It started last fall ...

When it comes to ADHD medication, let’s just say, it’s complicated. And maybe not for the reason you think. Simulants are a first-line treatment for ADHD—but they’re in short supply. The Food and Drug ...

Angela Myers is a freelance writer covering mental health, wellness and nutrition. She’s also conducted award-winning research on how to better communicate about sexual violence prevention and mental ...

The national ADHD medicine shortage, which has impacted access to generic versions of Adderall, Vyvanse, and Concerta, was first announced back in October 2022. Now, 16 months later, patients are ...